Article
Single alteration of p53 or E-cadherin genes can alter the surgical resection benefit in an experimental model of colon cancer.
Diseases of the colon and rectum - 1 Aug 2001
Pocard M, Debruyne P, Bras-Gonçalves R, Mareel M, Dutrillaux B, Poupon M F
Abstract excerpt
PURPOSE: p53 and E-cadherin mutations are associated with a high risk of metastatic potential and local recurrence after colorectal surgery. LoVo, a human colon cancer cell line expressing a wild-type p53 and a normal E-cadherin, was studied. Clone LoVo-XC17 was obtained from LoVo cells transfected with a vector bearing a p53 273his mutation. Clone LoVo-92R4 was obtained from LoVo by culture cells with an...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
